Awarded contract
Published
Antineoplastic and immunomodulating agents
4 suppliers have saved this notice.
Looks like a fit? Save this tender and qualify it in Stotles
Value
15,813,554 EUR
Current supplier
Centre spécialités pharmaceutiques
Description
Fourniture de médicaments Azacitidine, Bevacizumab, Erlotinib et Melphalan. Lot 5: melphalan. — lot 1: azacitidine, — lot 4: erlotinib. Lot 2: bevacizumab. Lot 3: bevacizumab.
Qualify tenders faster with AI summaries - see key details in the Stotles app
Unlock decision maker contacts.
Never miss a tender again
Get alerts, AI summaries and tools to qualify faster
Explore similar pre-tenders, open or awarded contracts
Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.
CHU de Poitiers
1,251,640 EUR
Published 2 years ago
Centre hospitalier universitaire
3,000,000 EUR
Published 2 years ago
CHU de Bordeaux
2,715,066.32 EUR
Published 2 years ago
Uniha GCS
2,840,857 EUR
Published 2 years ago
Centre hospitalier de Nevers
10,798,748.64 EUR
Published 2 years ago
Centre hospitalier Saint-Brieuc
967,667 EUR
Published 2 years ago
Explore top buyers for public sector contracts
Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.
CPV Codes
Sign up to the Stotles Tender Tracker for free
Find even more contracts with advanced search capability and AI powered relevance scoring.